DMP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Dermapharm Holding SE

Watchlist Manager

Watchlist

Price: 38.85 EUR

Market Cap: €5.1B

D	Dermapharm Holding SE XBER:DMP	DE
K	Koninklijke Philips NV XBER:PHI1	NL
	Koninklijke DSM NV AEX:DSM	NL
L	Littelfuse Inc F:LFS	US
	Industrias Penoles SAB de CV OTC:IPOAF	MX
	Continental AG XETRA:CON	DE
S	Salesforce Inc XMUN:FOO	US
	Morgan Stanley NYSE:MS	US
M	MGIC Investment Corp F:MGC	US
	LNA Sante SA PAR:LNA	FR
	Packaging Corp of America NYSE:PKG	US
J	Jabil Inc XMUN:JBL	US
	Capricor Therapeutics Inc NASDAQ:CAPR	US
	Komercni Banka as PSE:KOMB	CZ

Profitability Summary

Dermapharm Holding SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

64% > 68%

Healthy Operating Margin

20%

Sustainable 3Y Average Operating Margin

19%

Declining Operating Margin

22% > 20%

Healthy Net Margin

12%

Low 3Y Average Net Margin

Net Margin is Increasing

11% > 12%

Exceptional Free Cash Flow Margin

21%

Strong 3Y Average Free Cash Flow Margin

16%

Declining Free Cash Flow Margin

23% > 21%

Positive ROE

21%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.